The present invention relates to a cosmetic composition comprising in a physiologically acceptable medium an extract of pomegranate and an extract of peony.

A composition comprising at least one dispersed fatty phase, and at least one continuous aqueous phase, and comprising: a) at least one hydrophobic gelling agent selected from ester of dextrin and fatty acid; b) at least one amphiphilic crosslinked copolymer; c) at least one anionic terpolymer, linear or branched, of at least one monomer (1) carrying an acid function in free form, partially or totally salified by a nonionic monomer (2) selected from N,N-dimethylacrylamide and 2-hydroxyethyl acrylate, and at least one monomer (3) polyoxethylenated alkyl acrylate of formula (III) wherein in formula (III): R1 represents a hydrogen atom, R represents a linear or branched C.sub.8-C.sub.16 alkyl radical, n is an integer ranging from 1 to 10; and d) at least one hydrophobic particles chosen from hydrophobic silicas, hydrophobic cellulose, starch, talc, silicone resin powders, hollow hemispherical silicone particles, polyamide powders, hydrophobic pigments, or a mixture thereof. ##STR00001##

A soothing lip balm composition includes a wax binder component, which includes at least two compounds selected from a C.sub.8-C.sub.30 fatty acid, esterified C.sub.8-C.sub.30 fatty acid, and C.sub.8-C.sub.30 fatty alcohols; a complex fat component, which includes at least three different compounds selected from C.sub.8-C.sub.30 fatty acids; an organic compound component, which includes at least three compounds selected from 2,5-dimethoxy-p-cymene, cumene, thymol methyl ether, 2,6-diisopropylanisole, decanal, and 1,2,2,3-tetramethylcyclopent-3-enol; and an enzymatic component, which includes cysteine endopeptidase.

An oily stick-shaped cosmetic containing (A) a partially hydrogenated jojoba ester, (B) Japan wax, (C) a higher fatty acid, and (D) a dimer acid ester.

Disclosed herein are cohesive soft tissue fillers, for example, dermal and subdermal fillers, based on hyaluronic acids and pharmaceutically acceptable salts thereof. In one aspect, hyaluronic acid-based compositions described herein include a therapeutically effective amount of at least one anesthetic agent, for example, lidocaine. The present hyaluronic acid-based compositions including lidocaine have an enhanced stability and cohesivity, relative to conventional compositions including lidocaine, for example when subjected to sterilization techniques or when stored for long periods of time. Methods and processes of preparing such hyaluronic acid-based compositions are also provided.

A solid cosmetic composition including 12 to 50% by weight of a non-volatile liquid fatty phase and 40 to 85% by weight of a pulverulent phase including spherical fillers that are surface-treated with a metallic soap. Also, a process for preparing such a solid cosmetic composition and a method for making up the skin or lips using such a solid cosmetic composition.

The present invention relates to a kit comprising: at least one microneedle sheet (1) comprising a substrate layer and a plurality of microneedles on the substrate layer, the microneedles comprising at least one water-soluble or water-dispersible polymer; and a device comprising an applicator (2-3) comprising an application surface, a container (2-1) comprising a cosmetic composition and a valve, wherein the microneedle sheet (1) is capable being attached to the applicator (2-3) by attaching the substrate layer of the microneedle sheet to the application surface, the applicator (2-3), the container (2-1) and the valve are configured to supply the cosmetic composition via the valve onto the microneedle sheet (1). The kit according to the present invention can prevent the repeated use of microneedles (1), and can apply a cosmetic product in an easy and sanitary manner.

A dermal skin protectant and carrier comprising a combination of two different viscosity dimethicone components, wherein the difference between the two different viscosity dimethicone components is about 2.0 million cP or greater; and comprising at least one active ingredient.

A topical formulation comprising a Cannabis derived botanical drug product, wherein the concentration of each, cannabidiol and tetrahydrocannabinol, in the topical formulation is greater than 2 milligrams per kilogram.

The present invention relates to a composition comprising probiotics, preferably based on bacteria, in particular of the genus Lactobacillus, to be used for the purpose of preventing and/or treating the disorders affecting the skin, in particular inflammatory disorders, in particular autoinflammatory disorders of dermatological interest such as atopic dermatitis. Furthermore, the composition of the invention is useful for preventing and/or reducing the damage induced by UV radiation, in particular skin aging.